BMY
55
-8
WAT
48
-11
ADP
65
-3
LB
30
4
HRB
59
2
URBN
48
-6
STZ
52
-6
HBI
58
3
NWS
75
-4
MO
60
-2
VRSN
53
-5
MAR
63
-5
CNP
54
10
STX
45
-4
DAL
84
-3
DOV
65
-4
KMI
69
-2
PDCO
29
2
AAPL
40
-6
IR
63
-3
BMY
55
-8
WAT
48
-11
ADP
65
-3
LB
30
4
HRB
59
2
URBN
48
-6
STZ
52
-6
HBI
58
3
NWS
75
-4
MO
60
-2
VRSN
53
-5
MAR
63
-5
CNP
54
10
STX
45
-4
DAL
84
-3
DOV
65
-4
KMI
69
-2
PDCO
29
2
AAPL
40
-6
IR
63
-3
Financhill
Back

New Found Gold Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
20

NFG.V
New Found Gold

Last Price:
2.61
Seasonality Move:
-8.12%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
20
New Found Gold (NFG.V) is a Sell

Is New Found Gold a Buy, Sell or Hold?

  • The current New Found Gold [NFG.V] share price is $2.61. The Score for NFG.V is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NFG.V is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NFG.V Stock Price Chart

What is New Found Gold's stock price today?

  • The New Found Gold share price today is $2.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NFG.V is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NFG.V Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 33.17 Sell
Chaikin Money Flow: -178581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.86 - 3.5) Sell
Bollinger Bands (100): (3.2 - 3.98) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

NFG.V Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.84 Sell
20-day SMA: 3.12 Sell
50-day SMA: 3.35 Sell
200-day SMA: 4.17 Sell
8-day EMA: 2.8 Sell
20-day EMA: 3.03 Sell
50-day EMA: 3.3 Sell
200-day EMA: 4.05 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

New Found Gold Earnings Growth & NFG.V Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.06 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

New Found Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):